|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T69.1XXS |
Chilblains, sequela
|
T691XXS utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 18.60%
|
23.26%
|
16.28%
|
11.16%
|
6.51%
|
6.98%
|
2.79%
|
6.51%
|
2.33%
|
1.86%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T69.1XXS*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
99213
|
OFFICE O/P EST LOW 20 MIN |
14
|
14
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
11
|
11
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
9
|
9
|
|
80053
|
COMPREHEN METABOLIC PANEL |
5
|
5
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
5
|
5
|
|
86147
|
CARDIOLIPIN ANTIBODY EA IG |
5
|
10
|
|
86038
|
ANTINUCLEAR ANTIBODIES |
5
|
5
|
|
86146
|
BETA-2 GLYCOPROTEIN ANTIBODY |
4
|
11
|
|
G0467
|
FQHC VISIT, ESTAB PT |
3
|
3
|
|
83516
|
IMMUNOASSAY NONANTIBODY |
3
|
3
|
|
84165
|
PROTEIN E-PHORESIS SERUM |
3
|
3
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
2
|
2
|
|
80061
|
LIPID PANEL |
2
|
2
|
|
86160
|
COMPLEMENT ANTIGEN |
2
|
3
|
|
86235
|
NUCLEAR ANTIGEN ANTIBODY |
2
|
8
|
|
99214
|
OFFICE O/P EST MOD 30 MIN |
2
|
2
|
|
86140
|
C-REACTIVE PROTEIN |
2
|
2
|
|
85652
|
RBC SED RATE AUTOMATED |
2
|
2
|
|
86431
|
RHEUMATOID FACTOR QUANT |
2
|
2
|
|
93923
|
UPR/LXTR ART STDY 3+ LVLS |
1
|
1
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T69.1XXS related to the following DRG Codes:
922-923
|
